Global and Region Flu Vaccine (Influenza Vaccine) Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Flu Vaccine (Influenza Vaccine) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Flu Vaccine (Influenza Vaccine)market, defines the market attractiveness level of Flu Vaccine (Influenza Vaccine) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Flu Vaccine (Influenza Vaccine) industry, describes the types of Flu Vaccine (Influenza Vaccine) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Flu Vaccine (Influenza Vaccine) market and the development prospects and opportunities of Flu Vaccine (Influenza Vaccine) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Flu Vaccine (Influenza Vaccine) market in Chapter 13.

    By Player:

    • Mylan

    • Sanofi Pasteur

    • CSL

    • Pfizer

    • GSK

    • AstraZeneca

    • Johnson & Johnson

    By Type:

    • Whole Virus Vaccines

    • Split Virus Vaccines

    • Subunit Vaccines

    • Live Attenuated Virus Vaccines

    By End-User:

    • Live Attenuated Virus Vaccines

    • Live Attenuated Virus Vaccines

    • Live Attenuated Virus Vaccines

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Flu Vaccine (Influenza Vaccine) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Flu Vaccine (Influenza Vaccine) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Flu Vaccine (Influenza Vaccine) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Flu Vaccine (Influenza Vaccine) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Flu Vaccine (Influenza Vaccine) Market Analysis and Outlook to 2022

    • 7.1 Global Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

    • 7.2 United States Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

    • 7.3 Europe Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

    • 7.4 China Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

    • 7.5 Japan Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

    • 7.6 India Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

    • 7.7 South Korea Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

    8 Region and Country-wise Flu Vaccine (Influenza Vaccine) Market Analysis and Outlook to 2028

    • 8.1 Global Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

    • 8.2 United States Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

    • 8.3 Europe Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

    • 8.4 China Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

    • 8.5 Japan Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

    • 8.6 India Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

    • 8.7 South Korea Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

    9 Global Flu Vaccine (Influenza Vaccine) Market Outlook by Types and Applications to 2022

    • 9.1 Global Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Whole Virus Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Split Virus Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Subunit Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Live Attenuated Virus Vaccines Consumption and Growth Rate (2017-2022)

    • 9.2 Global Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Live Attenuated Virus Vaccines Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Live Attenuated Virus Vaccines Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Live Attenuated Virus Vaccines Consumption and Growth Rate (2017-2022)

    10 Global Flu Vaccine (Influenza Vaccine) Market Outlook by Types and Applications to 2028

    • 10.1 Global Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Whole Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Split Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Subunit Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Live Attenuated Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Live Attenuated Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Live Attenuated Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Live Attenuated Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

    11 Global Flu Vaccine (Influenza Vaccine) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Flu Vaccine (Influenza Vaccine) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Flu Vaccine (Influenza Vaccine) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Flu Vaccine (Influenza Vaccine) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Flu Vaccine (Influenza Vaccine) Market Competitive Analysis

    • 14.1 Mylan

      • 14.1.1 Mylan Company Details

      • 14.1.2 Mylan Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Mylan Flu Vaccine (Influenza Vaccine) Product and Service

    • 14.2 Sanofi Pasteur

      • 14.2.1 Sanofi Pasteur Company Details

      • 14.2.2 Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Product and Service

    • 14.3 CSL

      • 14.3.1 CSL Company Details

      • 14.3.2 CSL Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 CSL Flu Vaccine (Influenza Vaccine) Product and Service

    • 14.4 Pfizer

      • 14.4.1 Pfizer Company Details

      • 14.4.2 Pfizer Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Pfizer Flu Vaccine (Influenza Vaccine) Product and Service

    • 14.5 GSK

      • 14.5.1 GSK Company Details

      • 14.5.2 GSK Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 GSK Flu Vaccine (Influenza Vaccine) Product and Service

    • 14.6 AstraZeneca

      • 14.6.1 AstraZeneca Company Details

      • 14.6.2 AstraZeneca Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 AstraZeneca Flu Vaccine (Influenza Vaccine) Product and Service

    • 14.7 Johnson & Johnson

      • 14.7.1 Johnson & Johnson Company Details

      • 14.7.2 Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Johnson & Johnson Flu Vaccine (Influenza Vaccine) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Flu Vaccine (Influenza Vaccine)

    • Figure Flu Vaccine (Influenza Vaccine) Picture

    • Table Global Flu Vaccine (Influenza Vaccine) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Flu Vaccine (Influenza Vaccine) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Flu Vaccine (Influenza Vaccine) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Flu Vaccine (Influenza Vaccine) Consumption by Country (2017-2022)

    • Figure United States Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Table Europe Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure China Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Japan Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure India Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Global Flu Vaccine (Influenza Vaccine) Consumption Forecast by Country (2022-2028)

    • Figure United States Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Whole Virus Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Split Virus Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Subunit Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Live Attenuated Virus Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Live Attenuated Virus Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Live Attenuated Virus Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Live Attenuated Virus Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Whole Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Split Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Subunit Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Live Attenuated Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Live Attenuated Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Live Attenuated Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Live Attenuated Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Flu Vaccine (Influenza Vaccine) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Flu Vaccine (Influenza Vaccine) Export by Region (Top 5 Countries) (2017-2028)

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Flu Vaccine (Influenza Vaccine) Product and Service

    • Table Sanofi Pasteur (Foundation Year, Company Profile and etc.)

    • Table Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Product and Service

    • Table CSL (Foundation Year, Company Profile and etc.)

    • Table CSL Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Flu Vaccine (Influenza Vaccine) Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Flu Vaccine (Influenza Vaccine) Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Flu Vaccine (Influenza Vaccine) Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Flu Vaccine (Influenza Vaccine) Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Flu Vaccine (Influenza Vaccine) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.